This MODDERN Cures proposal, the sponsors point out it is only for therapies that address an unmet medical need for serious or life-threatening diseases.
These core values represent a commitment that stretches all the way back to the founding of our country.
And that could be a huge windfall?
In a biosimilars provision in the Affordable Care Act, we gave 12 years of exclusivity to biologics.
Well, you mentioned the evergreening provision in your testimony.
The foundation laid by the Hatch-Waxman Act thirty years ago will continue to be the mechanism by which the government i...
The foundation laid by Hatch-Waxman Act 30 years ago will continue to be the mechanism by which the management incentive...
This hearing today has very real implications for patients everywhere. How do we ensure that drug and device companies h...
We cannot legislate scientific advances. In some areas, the lack of new treatments is attributable to a lack of scientif...
We cannot rest on our laurels. We have an obligation to periodically reevaluate and adjust to account for the sweeping c...
the incentives are clearly not there to drive the innovation we need for many of the conditions.